Clinical Trials Browser

Pancreatic Neoplasms

Hematologic Diseases

Triple Negative Breast Neoplasms

Esophageal Squamous Cell Carcinoma

Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited

Hawthorn Red Combined Refractory Cancer Pain

Glioblastoma

Digestive System Tumors

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Triple Negative Breast Neoplasms

Colorectal Neoplasms

Non-squamous Cell Non-Small Cell Lung Cancer

Recurrence, Lymphoma, B-Cell

Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell

Neoplasms, Plasma Cell

Immunotherapy

Lymphoma, Lymphoma, Non-Hodgkin, Recurrence

Burkitt Lymphoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Insulin Resistance, Ketosis

Lymphoma, B-Cell

Submucosal Tumor of Stomach

Rectal Neoplasms

Meningioma, Neurologic Manifestations

Gastric Subepithelial Tumor

Leukemia, Myeloid, Acute

Neuronopathy, Distal Hereditary Motor, Type IIB, Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Gastrointestinal Neoplasms, Neoplasm Metastasis, Stomach Neoplasms, Colorectal Neoplasms

Neoplasms, Plasma Cell

Clinical Trials

Maintenance Ipilimumab + Nivolumab Post Induction Chemotherapy + SBRT for First Line Treatment Stage IV Pancreatic Cancer

Allogeneic γ9δ2 T Cells Treatment of Recurrent Hematologic Tumors

Targeting Metastatic Breast Cancers by Alkaline Glucosodiene Molecules Via a Metabolic Pathway Phase I Clinical Trial

An Exploratory Single-arm Study: PD-1 With Recombinant Human Adenovirus Type 5 Injection for Malignant Melanomas

XH-30002 Capsule Combined With Afatinib Tablets for the Treatment of Squamous Cell Carcinoma

Assessment of Safety and Efficacy of ThisCART19A in Adult Patients With B Cell Malignancies After Failure of Autologous Chimeric Antigen Receptor T- Cell(CAR-T) Therapy

Phase Ⅰa Clinical Study of Hawthorn Red Pigment Combined With Standard Analgesic for Refractory Cancer Pain

Nk Cell Therapy for Recurrent Glioblastoma Multiform Patients

A Trail of CDK4 / 6 Inhibitor and MEK Inhibitor in the Treatment of Metastatic Digestive System Tumors

Sequentional Immuno Apheresis Plasma Volume Escalation Cohort Study of Reduction of Soluble Tumor Necrosis Factor Receptors 1 and 2 (sTNFR1/2) With or Without Nivolumab in Patients With Inoperable or Metastatic Solid Tumors

The Safety and Tolerability of PD-L1 Monoclonal Antibody Plus Lenalidomide in The Treatment of Colorectal Cancer

Anlotinib Combined With Pemetrexed And Carboplatin as First-line Treatment in Advanced Nonsquamous NSCLC

An Immunogenic Personal Neoantigen Vaccine for Cancer Treatment

Fecal Microbiota Transplantation (FMT) in Metastatic Melanoma Patients Who Failed Immunotherapy

CD19/20 Bispecific Nanobody-derived CAR-T Cells in B Cell Lymphoma

Cord Blood Derived CAR-T Cells in Refractory/Relapsed B Cell Malignancies

BCMA-CAR-T in Relapsed/Refractory Multiple Myeloma

NK Cells Infusion for Advanced Malignancies

Cytoplasmic Activated PD-1 CAR T Cells in Refractory/Relapsed B Cell Lymphoma

The Safety and Efficacy of CART-19 Cells in B-cell Acute Lymphoblastic Leukemia (B-ALL).

SMC 0712-13

The Safety and Efficacy of CART-19 Cells in Relapse and Refractory Patients With CD19+ B-cell Lymphoma

Endoscopic Full Thickness Resection Without Exposure to Peritoneum

Selinexor Combined With Standard Chemoradiation as Neoadjuvant Treatment in Locally Advanced Rectal Cancer

Hyperbaric Oxygen Therapy Can Improve Neurological State Post Meningioma Removal Surgery

EFTR-LA

Everolimus (RAD001) in Elderly Patients With Acute Myeloid Leukemia

A Study for Treatment of Superficial Bladder Cancer Using OGX-427

TIROX

Atorvastatin in Myeloma